Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials

被引：0
|
作者：
Khosro Keshavarz
Farhad Lotfi
Ehsan Sanati
Mahmood Salesi
Amir Hashemi-Meshkini
Mojtaba Jafari
Mohammad M. Mojahedian
Behzad Najafi
Shekoufeh Nikfar
机构：
[1] School of Management and Information Sciences,Health Human Resources Research Center, Department of Health Economics
[2] Shiraz University of Medical Sciences,Department of Pharmacoeconomics and Pharmaceutical Administration
[3] Faculty of Pharmacy,Atherosclerosis Research center
[4] Tehran University of Medical Sciences,Iranian center of Excellence in health management, Department of health services management
[5] Baqiyatallah University of Medical Sciences,Department of Pharmacoeconomics and Pharmaceutical Administration
[6] School of management and medical informatics,undefined
[7] Tabriz University of medical sciences,undefined
[8] Faculty of Pharmacy and Evidence-Based Medicine Group,undefined
[9] Pharmaceutical Sciences Research Center,undefined
[10] Tehran University of Medical Sciences,undefined
来源：
DARU Journal of Pharmaceutical Sciences | / 25卷
关键词：
Linagliptin; Type 2 diabetes mellitus; Sitagliptin; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials
    Keshavarz, Khosro
    Lotfi, Farhad
    Sanati, Ehsan
    Salesi, Mahmood
    Hashemi-Meshkini, Amir
    Jafari, Mojtaba
    Mojahedian, Mohammad M.
    Najafi, Behzad
    Nikfar, Shekoufeh
    [J]. DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [2] Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials
    Aljohani, Hadir
    Alrubaish, Fares S.
    Alghamdi, Waad M.
    Al-Harbi, Fawaz
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (04) : 622 - 633
  • [3] Effects of Sitagliptin on Lipid Profiles in Patients With Type 2 Diabetes Mellitus A Meta-analysis of Randomized Clinical Trials
    Fan, Minhua
    Li, Yuelan
    Zhang, Shihong
    [J]. MEDICINE, 2016, 95 (02)
  • [4] Sitagliptin and risk of hypertension in patients with type 2 diabetes mellitus: meta-analysis of randomized trials
    Zhang, B.
    Zhong, Y. I.
    Lu, Z.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 877 - 878
  • [5] Risk of diarrhea in patients with type 2 diabetes mellitus treated with sitagliptin: a meta-analysis of 30 randomized clinical trials
    Zhao, Qingwei
    Hong, Dongsheng
    Zheng, Dongsheng
    Xiao, Yao
    Wu, Baohua
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 2283 - 2294
  • [6] Sitagliptin and risk of hypertension in patients with type 2 diabetes mellitus: meta-analysis of randomised trials
    Zhang, B.
    Lu, Z.
    [J]. DIABETOLOGIA, 2015, 58 : S547 - S548
  • [7] Efficacy and safety of sitagliptin in patients with type 2 diabetes mellitus: a meta-analysis
    Zhao, Jun-Yu
    Wang, Hai-Peng
    Wang, Huan-Jun
    Yao, Jin-Ming
    Wu, Xiao-Yun
    Dong, Jian-Jun
    Liao, Lin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11202 - 11210
  • [8] BROMOCRIPTINE FOR THE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RANDOMIZED CONTROLLED CLINICAL TRIALS
    Dasari, A.
    Gudala, K.
    Bansal, D.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S13 - S13
  • [9] Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Aljohani, H.
    Alrubaish, F. S.
    Alghamdi, W.
    Al-Harbi, F.
    Al-Fadel, N.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1162 - 1163
  • [10] Metformin versus insulin in gestational diabetes mellitus: a meta-analysis of randomized clinical trials
    Zhu, B.
    Zhang, L.
    Fan, Y. Y.
    Wang, L.
    Li, X. G.
    Liu, T.
    Cao, Y. S.
    Zhao, Z. G.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 (02) : 371 - 381
12345